MGRM Earnings Prediction
The chart below shows how MGRM performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MGRM sees a +9.88% change in stock price 10 days leading up to the earnings, and a +3.97% change 10 days following the report. On the earnings day itself, the stock moves by +0.68%. This data can give you a slight idea of what to expect for the next quarter's release.
MGRM Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
0.00
--
--
Gross Margin
--
--
--
Operating Margin
--
--
--
Net Margin
--
--
--
EPS
-0.16
-433.33%
45.45%
No Data Available
MGRM Earnings Analysis
Monogram Technologies Inc. Common Stock Corporation (MGRM.O) Earnings Conference Call
Positive
Strong Liquidity Position: The company reported $16.5 million in cash at the end of Q3 2024, indicating strong liquidity.
Effective Cash Management: Operating cash flow year-to-date is $10.9 million, reflecting effective cash management.
Capital Raising Success: The company generated $13.99 million from financing activities, showcasing successful capital raising efforts.
Employee Stability: The team maintained a consistent number of 27 full-time employees, ensuring stability in operations.
Strong Financial Position: The company is well-positioned to meet its obligations with a strong balance sheet, indicating financial health.
Negative
Cash Flow Decline Indicator: Operating cash flow year-to-date is $10.9 million, which works out to be about a $1.2 million cash run rate, indicating a potential decline in cash generation.
External Funding Reliance: The company had a significant financial raise, generating $13.99 million from financing activities, which may indicate reliance on external funding rather than organic growth.
Variable Cost Structure Impact: The company continues to have a highly variable cost structure, which could lead to unpredictability in financial performance and profitability.
Clinical Trial Delays: The company has not provided any specific dates for the clinical trial clearance, indicating potential delays in operational timelines.
High Marketing Expense Impact: The marketing expense in the quarter was high, suggesting increased spending without guaranteed returns, which could impact overall profitability.
MGRM FAQs
How does MGRM typically perform around its earnings report dates?
Is Monogram Technologies Inc. (MGRM) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
MGRM Earning Call Sentiment
Monogram Technologies Inc. (MGRM) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
MGRM.O
0%Positive
The earnings call reveals a mix of positive and negative factors. The positive aspects include a strong cash position, oversubscribed financing activities, and strategic plans for international expansion. However, uncertainties in FDA clearance timelines, competitive pressures, and lack of specific revenue guidance temper the optimism. The Q&A section highlights management's inability to provide precise timelines and market entry specifics, adding to the uncertainty. These mixed signals suggest a neutral stock price movement in the short term.
